These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 12700959
41. High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kim JS, Bellew CA, Silverstein DM, Aviles DH, Boineau FG, Vehaskari VM. Kidney Int; 2005 Sep; 68(3):1275-81. PubMed ID: 16105061 [Abstract] [Full Text] [Related]
44. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children]. Norero C, Delucchi A, Lagos E, Rosati P. Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508 [Abstract] [Full Text] [Related]
45. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS]. Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S. Nihon Jinzo Gakkai Shi; 2010 May; 52(8):1029-36. PubMed ID: 21254699 [Abstract] [Full Text] [Related]
51. Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis. Schijvens AM, Teeninga N, Dorresteijn EM, Teerenstra S, Webb NJ, Schreuder MF. Eur J Pediatr; 2021 Sep; 180(9):2849-2859. PubMed ID: 33774744 [Abstract] [Full Text] [Related]
53. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group. Hogg RJ, Fitzgibbons L, Bruick J, Bunke M, Ault B, Baqi N, Trachtman H, Swinford R. Clin J Am Soc Nephrol; 2006 Nov; 1(6):1173-8. PubMed ID: 17699344 [Abstract] [Full Text] [Related]
54. [Treatment of idiopathic nephrotic syndrome with cyclosporin A]. Ariceta Iraola G, Rodríguez Soriano J, Vallo Boado A, Quintela Pérez MJ, Oliveros Pérez R. An Esp Pediatr; 1997 Sep; 47(3):273-8. PubMed ID: 9499280 [Abstract] [Full Text] [Related]
55. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome. Dinçel N, Yılmaz E, Kaplan Bulut İ, Hacıkara Ş, Mir S. Ren Fail; 2015 Sep; 37(8):1267-72. PubMed ID: 26313331 [Abstract] [Full Text] [Related]
58. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A. Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428 [Abstract] [Full Text] [Related]
59. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410 [Abstract] [Full Text] [Related]
60. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E. Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]